HOMESeminars & Presentations2017 Organizer Seminars / Sponsor Seminars / Luncheon Seminars

2017 Organizer Seminars /
Sponsor Seminars /
Luncheon Seminars

Oct. 11 (Wed.)

Oct. 12 (Thu.)

Oct. 13 (Fri.)

Keynote Lectures

Date & Time: Oct. 11 (Wed.) 10:00-11:30
Venue: Annex Hall F203-206

Connecting Digital and Bio Technology for Future Innovation
- Toward the Realization of “Society 5.0” -

Toshiaki Higashihara

President & CEO, Hitachi
(Vice Chairman, Japan Electronics and Information Technology Industries Association)

Gladys H. Monroy

BioScience and Technology development in Singapore, Policy and Outcome

David Lane

Chief Scientist, A*STAR; Director, p53 Lab

The Future of Pharmaceutical Innovation

Yoshihiko Hatanaka

President,
Japan Pharmaceutical Manufacturers Association

■Organizer Seminar

■Luncheon Seminar

*Visitor registration is required to attend the seminars. Registration for the seminars is scheduled to begin in September.

*Special sessions and Organizer seminars are subject to a fee of 5,000 yen (Fee covers all three days. Fee does not apply to Partnering participants).

*The program is subject to change.

Oct.10 (Tue.)

F201 F202 F203 F204 F205 F206
9:00-
18:00

Oct. 11(Wed.)

F201 F202 F203 F204 F205 F206
9:30-
10:00
10:00-
10:30

<Keynote Speech>

The Future of Pharmaceutical Innovation

Simultaneous
Interpretation

10:30-
11:00
11:00-
11:30
11:30-
12:00
12:00-
12:30

【L-1】 Government of Canada

The 8th Canada Life Sciences Seminar @ BioJapan "Novel Approaches to Address Unmet Medical Needs in Neurodegenerative Disorders --- Opportunities in Canada for Investment, Innovation and Business"

英語進行

【L-2】 Bayer Yakuhin

Joining forces with Bayer in Drug Discovery & Development

Simultaneous
Interpretation

12:30-
13:00

【O-1】 Life-Innovation Forum - Current Status and Issues on Policies for Medical Innovation

Simultaneous
Interpretation

13:00-
13:30
13:30-
14:00
14:00-
14:30
14:30-
15:00
15:00-
15:30

【O-2】 Industrialization of Regenerative Medicine in Asia-Pacific region

Simultaneous
Interpretation

英語進行

15:30-
16:00

【O-3】 Bioeconomy Strategies Around the World

Simultaneous
Interpretation

16:00-
16:30
16:30-
17:00
17:00-
17:30

Oct. 12(Thu.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

【O-4】 Bio-cluster summit 2017

Simultaneous
Interpretation

【O-5】 Cancer immunotherapy targeting regulatory T cells

Simultaneous
Interpretation

<Special Session>Solutions provided by KANEKA using Biotechnology

Simultaneous
Interpretation

10:00-
10:30

【O-6】 Evolutional findings/technology in Microbiology ~Toward next generation~

Simultaneous
Interpretation

10:30-
11:00
11:00-
11:30
11:30-
12:00

【O-7】 Gene Therapy Update
― Commercialization of CAR-T and TCR-T gene therapy; Progress and Challenges ―

Simultaneous
Interpretation

12:00-
12:30

【L-3】 Germany Trade and Invest

Make the most of your research and development partnerships - Find your German match

Simultaneous
Interpretation

【L-4】 Nikon CeLL innovation / Lonza Japan

Development of cGMP compliant manufacturing processes that ensure safety and quality of Cell Therapy/Gene Therapy products for regenerative medicine: our approach and experience

Simultaneous
Interpretation

【L-5】 Takeda Pharmaceutical

The establishment of Drug Discovery Ecosystem by partnership with industry, government and academia

Simultaneous
Interpretation

Japanese
Session

12:30-
13:00
13:00-
13:30
13:30-
14:00

【O-8】 Forefront of biopharmaceutical manufacturing
-Continuous production technology enabled by advanced ICT technology-

Simultaneous
Interpretation

14:00-
14:30
14:30-
15:00
15:00-
15:30

【O-9】 R&D of RM products in Japan

Simultaneous
Interpretation

15:30-
16:00

【O-10】 Industrial creations by ecosystem control - new avenues opened by omics technologies -

Simultaneous
Interpretation

【O-11】 Reality and Challenge of Medical Big Data

Simultaneous
Interpretation

16:00-
16:30
16:30-
17:00
17:00-
17:30

Oct. 13(Fri.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

【O-12】 Go for intensify of "Foods with Function Claims" system ~ What is evidence data that should be conveyed to consumers?

Japanese
Session

【O-13】 Update on iPS cell’s Research and Innovation

Simultaneous
Interpretation

10:00-
10:30
10:30-
11:00
11:00-
11:30

【O-14】 Present and Perspective of microbiome science in the maintenance and control of human health

Simultaneous
Interpretation

【O-15】 What Pharma needs to do in an era of degital with a changing healthcare ecosystem

Simultaneous
Interpretation

11:30-
12:00
12:00-
12:30

【L-6】 1st RORZE LifeScience Seminar

Application of human iPS cells for drug discovery

Japanese
Session

【L-7】 Metabolon

Precision Metabolomics™ Illuminates New Paths for Medicine and Pharmaceutical R&D

英語進行

12:30-
13:00
13:00-
13:30
13:30-
14:00
14:00-
14:30
14:30-
15:00
15:00-
15:30

【O-16】 Food, Agriculture and Fishery Industries and its Value Chain with using AI and IoT

Simultaneous
Interpretation

【O-17】 Genome editing legal aspect and industrial application now and future

Simultaneous
Interpretation

【O-18】 Innovate Healthcare in Aging Society!!

Simultaneous
Interpretation

【O-19】 Emerging technologies and products in Regenerative Medicine

Simultaneous
Interpretation

15:30-
16:00

【O-20】 Recent progress in development of nucleic acid therapeutics

Simultaneous
Interpretation

16:00-
16:30
16:30-
17:00
17:00-
17:30

TOPへ戻る

| Sitemap |

© 2017 JTB Communication Design, Inc. All rights reserved.